CNCR

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

CNCR was delisted on the 27th of May, 2025.

Back to rankings

11 hedge funds and large institutions have $2.52M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$745K
2
+$349K
3
+$76.6K
4
BBPWM
Blue Bell Private Wealth Management
Pennsylvania
+$9.5K

Top Sellers

1
-$1.11M
2
-$220K
3
-$17K
4
TRCT
Tower Research Capital (TRC)
New York
-$667
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$864K
2
$745K
3
$593K
4
$247K
5
$23K
6
$19K
7
$15K
8
$4K
9
$2K
10
$2K
11
$1K
12
–
13
–